SLN (Silence Therapeutics Corp) Bozor qiymatining balans qiymatiga nisbati

Silence Therapeutics Inc. (SLN) - korporativ logo

Silence Therapeutics (SLN) narxlar grafigi innovatsion DNKga asoslangan dori vositalarini ishlab chiqayotgan kompaniyaning dinamikasini aks ettiradi. Biznes kardiologik va ghematologik patologiyalar uchun dori vositalarini bozorga chiqarishda global sog'liqni saqlash gigantlari bilan strategik ittifoqlarga tayanadi, bunda ko'rsatkich 24.28 darajasida turibdi. Ishlab chiqarish quvvatlari Yevropa va AQSh o'rtasida taqsimlangan, brendning siRNA sohasidagi ilmiy nufuzi esa muvaffaqiyatli klinik sinovlar bilan tasdiqlangan.

Silence Therapeutics (SLN) - Bozor kapitallashuvining balans qiymatiga nisbati 21.06.2023dan 28.10.2026gacha

Silence Therapeutics PLC (SLN) moliyaviy va bozor koʻrsatkichlari kesimi

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi Silence Therapeutics|SLN - Investitsiya uylarining umumiy prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Silence Therapeutics Inc.|SLN - Biznes qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati Silence Therapeutics|SLN - Balans kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati silence-therapeutics.com|SLN - Kompaniya aktivlarining umumiy hajmi
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati Silence Therapeutics|SLN - Uzoq muddatli qarzdorlikning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Silence Therapeutics Inc.|SLN - Kompaniya qarzlari|Balans kapitallashuviga qarzlar Silence Therapeutics Inc.|SLN - Uzoq muddatli qarz|Kompaniyaning qisqa muddatli qarzi Silence Therapeutics
Kompaniyaning dastlabki tahlili:Silence Therapeutics
Silence Therapeutics Inc. tomonidan chiqariladigan mahsulotlar

Investor uchun Silence Therapeutics (SLN) kompaniyasini baholash bozor kutuvlari va ushbu biotexnologiya kompaniyasining haqiqiy aktivlari o'rtasidagi farqni tahlil qilishni talab qiladi. Narxning buxgalteriya qiymatiga nisbati tendentsiyasini tahlil qilish orqali biz sof aktivlarga nisbatan kapitalning haddan tashqari yuqori baholanganlik koeffitsiyentini aniqlaymiz, bu esa minimal operatsion faoliyatga ega bo'lgan va balans bazasini belgilovchi bio-chiqindilarni utilizatsiya qilish bo'yicha standart ekologik xarajatlari mavjud bo'lgan kompaniyalar uchun juda muhimdir.

Toʻgʻridan-toʻgʻri raqobatchilar

Bozor kapitallashuvining balans qiymatiga nisbati Tempus Labs|QGEN (qiagen.com) - Kapitallashuvning balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Ionis (IONS)|Kapitallashuvning balans qiymatiga nisbati Repligen Corp|Bozor kapitallashuvining balans qiymatiga nisbati RNA|Bozor kapitallashuvining balans qiymatiga nisbati CRSP (CRISPR)|Bozor qiymatining balans qiymatiga nisbati WGS|Balans qiymatiga nisbatan bozor kapitallashuvi ultragenyx.com RARE|Bozor kapitallashuvining balans qiymatiga nisbati BEAM (Beam Therapeutics)|SRPT: Balans qiymatiga nisbatan bozor kapitallashuvi|Twist Bio (TWST) - Bozor qiymatining balans qiymatiga nisbati|10x (TXG) - Bozor qiymatining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati NTLA (Intellia Therapeutics)|Bozor qiymatining balans qiymatiga koeffitsiyenti STOK|Bozor qiymatining balans qiymatiga nisbati BioLife Solutions BLFS|Kapitallashuvning balans qiymatiga nisbati Wave Life Sciences Ltd (WVE)|Maze Tx - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Sionna Corp SION|PRME (Prime Medicine, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|tayshagtx.com (TSHA) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Kapitallashuvning sof aktivlarga nisbati uniQure QURE|Balans qiymatiga nisbatan bozor qiymati MeiraGTx Holdings|Regenxbio (RGNX) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga multiplikatori Solid Corp|Ocugen, Inc. (OCGN) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati pacb.com (PACB)|BNTC: Bozor kapitallashuvining balans qiymatiga nisbati|Design Therapeutics Inc - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Rocket Pharmaceuticals Inc (RCKT)|FDMT - Balans qiymatiga nisbatan bozor qiymati|LXEO: Bozor kapitallashuvining balans qiymatiga nisbati|KRRO (Korro Bio) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Editas Medicine EDIT|Sof aktivlarga nisbatan bozor kapitallashuvi ProQR Therapeutics NV|Codexis, Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Sangamo BioSciences SGMO|Kapitallashuvning sof aktivlarga nisbati NAUT (Nautilus Bio)|MGX - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Precision BioSciences DTIL|GBIO - Bozor kapitallashuvining balans qiymatiga multiplikatori|Boundless Bio, Inc - Bozor kapitallashuvining balans qiymatiga nisbati|Exicure (XCUR) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati IMNN|Kapitallashuvning sof aktivlarga nisbati PHIO|MBIO (Mustang Bio, Inc.) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi RNAZ (transcodetherapeutics.com)|Bozor qiymatining balans qiymatiga nisbati BNGO|Applied DNA Corp - Balans qiymatiga nisbatan bozor kapitallashuvi|BLUE - Bozor qiymatining balans qiymatiga nisbati|IPA: Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Omega Therapeutics, Inc.|Singular Genomics Systems, Inc. (OMIC) - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Regulus Therapeutics Inc (RGLS)|Kapitallashuvning balans qiymatiga nisbati SYRS|Bozor qiymatining balans qiymatiga nisbati Telesis Bio, Inc. TBIO|Kapitallashuvning balans qiymatiga nisbati traconpharma.com (TCON)|Bozor kapitallashuvining balans qiymatiga nisbati UBX (Unity Biotechnology, Inc.)